الولايات المتحدة · مجلات اقتصادية · Quartz

Amgen's cancer drug combo cut death risk by 58% in lung cancer trial

نشره Quartz · الولايات المتحدة منذ 2 س

Median survival reached 21.1 months with Imdelltra plus AstraZeneca's Imfinzi, versus 12.7 months for Imfinzi alone

اقرأ المقال كاملًا على Quartz سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (qz.com)

يستحق القراءة أيضًا

Why Marketing Engineers Are Becoming the Most Dangerous Advantage in the Age of AI Search

My Co-Worker Hung a Bloody Head Over Our Desks. Is This Normal Office Halloween Decor?

A one-person quorum: no discussion, no dissent, no disclosure at the SEC

Anthropic files SEC paperwork as AI giant prepares for major IPO

7 Reasons Why You Should Consider a Roth 401(k)

How U.S. home sellers are helping buyers make a deal in a stagnant housing market